Toshifumi Mikayama
Directeur/Membre du Conseil chez KYOWA KIRIN CO. LTD.
Postes actifs de Toshifumi Mikayama
Sociétés | Poste | Début | Fin |
---|---|---|---|
KYOWA KIRIN CO. LTD. | Directeur/Membre du Conseil | 01/03/2014 | - |
Corporate Officer/Principal | 01/10/2008 | - | |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Directeur/Membre du Conseil | 07/03/2012 | - |
Historique de carrière de Toshifumi Mikayama
Statistiques
Internationale
Japon | 2 |
Royaume-Uni | 2 |
Opérationnelle
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
KYOWA KIRIN CO. LTD. | Health Technology |
Entreprise privées | 1 |
---|---|
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Toshifumi Mikayama
- Expérience